[Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].
暂无分享,去创建一个
[1] M. Schwaiger,et al. Imaging Gastric Cancer with PET and the Radiotracers 18F-FLT and 18F-FDG: A Comparative Analysis , 2007, Journal of Nuclear Medicine.
[2] H. Katoh,et al. Evaluation of 18F-2-deoxy-2-fluoro-d-glucose Positron Emission Tomography for Gastric Cancer , 2004, World Journal of Surgery.
[3] J. Takita,et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma , 2005, Cancer.
[4] P. Dupont,et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Y. Bang,et al. The role of PET/CT in detection of gastric cancer recurrence , 2009, BMC Cancer.
[6] K. Kang,et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[7] M. Schwaiger,et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Lin Chen,et al. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies , 2004, Nuclear medicine communications.
[9] D. Visvikis,et al. Use of Positron Emission Tomography in Surgery Follow-Up of Esophageal Cancer , 2009, Journal of Gastrointestinal Surgery.
[10] P. Conti,et al. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. , 2003, Clinical radiology.
[11] Manish A Shah,et al. Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. , 2011, World journal of gastroenterology.
[12] A. Patriti,et al. [Postoperative follow-up of gastric adenocarcinoma with neoplastic markers and 18-FDG-PET/TC]. , 2007, Annali italiani di chirurgia.
[13] H. Groen,et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M. Schwaiger,et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Woo Jin Hyung,et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography , 2005, Cancer.
[16] M. Schwaiger,et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[17] S. Larson,et al. Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience. , 1998, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[18] Y. Nishiyama,et al. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[19] Wolfgang A Weber,et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.
[20] 김주희,et al. Comparison of CT and 18F-FDG PET for Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcinoma , 2006 .
[21] Zheng Fu,et al. Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus , 2007, Journal of Nuclear Medicine.
[22] P. Bartenstein,et al. Positron Emission Tomography for Staging Esophageal Cancer: Does It Lead to a Different Therapeutic Approach? , 2003, World Journal of Surgery.
[23] S. Fanti,et al. The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab , 2007, Gastric Cancer.
[24] J. Lee,et al. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] H. Isozaki,et al. Usefulness of preoperative FDG-PET for detection of gastric cancer , 2006, Gastric Cancer.
[26] T. Saga,et al. Positron emission tomography for the diagnosis and management of patients with gastrointestinal malignancies. , 2008, Gastrointestinal endoscopy clinics of North America.
[27] J. Shirlaw. THE METABOLISM OF TUMOURS , 1931 .
[28] H. Furukawa,et al. Is PET-CT suitable for predicting lymph node status for gastric cancer? , 2008, Hepato-gastroenterology.
[29] H. Fukuda,et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] V. Lowe,et al. Comparison of Positron Emission Tomography, Computed Tomography, and Endoscopic Ultrasound in the Initial Staging of Patients with Esophageal Cancer , 2005, Molecular Imaging and Biology.